Life Technologies acquires Navigenics
Navigenics has been acquired by biotechnology firm Life Technologies.
Biotechnology company Life Technologies has confirmed it has acquired genetics specialist Navigenics in a deal that may have required negotiation techniques.
The enterprise explained Navigenics' multidisciplinary expertise in areas such as technology infrastructure, user interfaces, online platforms and genomic support services will be highly valuable to Life Technologies' expanding molecular diagnostics business.
Ronnie Andrews, president of Medical Sciences at Life Technologies, said: "The advent of personalised medicine will require a combination of technologies and informatics focused on delivering relevant information to the treating physician."
The genetic analysis functions performed by Navigenics will therefore play a pivotal role in offering more detailing information about patients, resulting in increasingly effective individual treatment programmes.
Gregory Lucier, chairman and chief executive officer of Life Technologies, explained the Navigenics informatics platform will allow his company to "transform the data from our instrument systems into actionable information" that can then be delivered in real-time to physicians around the world.
Life Technologies operates in more than 160 countries, providing more than 50,000 products in sectors such as agricultural biotechnology, molecular medicine and diagnostics, stem cell-based therapies, forensics, food safety and animal health.
Posted by David Gleck
Soruce: Life Technologies press release, July 16th